pulmonari
fibrosi
sever
patholog
outcom
associ
sever
lung
diseas
commonli
reproduc
intratrach
instil
bleomycin
cytotox
chemotherapeut
agent
tissu
remodel
ensu
character
sever
inflamm
evid
edema
leukocyt
migrat
delay
phase
fibroblast
prolifer
excess
matrix
deposit
patholog
event
lead
pulmonari
fibrosi
attribut
overproduct
interstiti
collagen
cytokineactiv
fibroblast
moreov
though
varieti
cytokin
implic
fibroblast
activ
paramount
caus
role
transform
growth
factor
tgf
emerg
cytokin
activ
fibroblast
differenti
myofibroblast
stimul
extracellular
matrix
ecm
product
howev
besid
profibrot
properti
exert
number
homeostat
function
immun
cancer
biolog
inhibit
would
provok
seri
advers
effect
make
valuabl
therapeut
approach
therapeut
intervent
includ
antiinflammatori
drug
eg
glucocorticoid
prednison
effect
reliev
diseas
without
halt
fibrosi
progress
antifibrot
drug
improv
lung
function
life
expect
use
may
also
associ
harm
side
effect
nonetheless
knowledg
underli
mechan
pulmonari
fibrosi
increas
might
help
identif
target
amen
develop
novel
therapi
great
interest
biochem
pathway
center
endogen
inhibitor
endow
counterregulatori
protect
function
studi
focus
acut
inflamm
elucid
endogen
antiinflammatori
pathway
oper
parallel
sometim
timedelay
fashion
wide
studi
proinflammatori
mediat
ensur
rapid
resolut
host
respons
return
tissu
homeostasi
one
line
research
focus
glucocorticoidregul
protein
annexin
amino
acid
long
kda
protein
potent
modul
leukocyt
traffickingtransmigr
acut
chronic
inflamm
particular
abil
inhibit
leukocyteendothelium
interact
microvasculatur
character
null
mous
coloni
reveal
upon
stimul
dysregul
pathophysiolog
mechan
exacerb
acut
chronic
experiment
inflammatori
respons
protein
highli
express
airway
humananim
alveolar
macrophag
epitheli
cell
find
explain
constitut
gene
promot
activ
bronchial
epithelium
lung
endotheli
cell
antiinflammatori
effect
replic
shorter
peptid
span
first
amino
acid
term
peptid
ntermin
deriv
peptid
exert
potent
regul
inflammatori
reaction
activ
receptor
formylpeptid
receptor
fpr
consequ
inhibit
white
blood
cell
traffick
promot
efferocytosi
interest
context
lung
inflamm
downregul
endogen
express
note
bronchoalveolar
lavag
bal
fluid
cystic
fibrosi
patient
recent
blockad
transmembran
conduct
regul
protein
cftr
led
releas
human
mous
neutrophil
find
associ
alter
acut
inflammatori
reaction
background
present
studi
undertaken
compar
cellular
tissu
macroscop
alter
observ
model
bleomycininduc
lung
fibrosi
wild
type
null
mice
moreov
pattern
express
endogen
protein
gene
promot
activ
monitor
pharmacolog
potenti
peptidomimet
assess
male
wild
type
null
mice
g
bodi
weight
maintain
standard
chow
pellet
diet
tap
water
ad
libitum
use
experi
anim
hous
densiti
five
anim
per
cage
room
control
light
light
pm
temperatur
maintain
anim
work
perform
accord
uk
home
offic
regul
guidanc
oper
anim
scientif
procedur
act
committe
ethic
anim
research
famerp
sp
brazil
protocol
along
direct
european
union
pulmonari
fibrosi
induc
intratrach
administr
bleomycin
blenoxan
mead
johnson
princeton
nj
suspend
steril
phosphatebuff
salin
pb
ukg
control
mice
receiv
salin
vehicl
n
per
group
differ
time
post
intratrach
inject
day
mice
anesthet
ketamin
dopalen
vetbrand
brazil
xylazin
anasedan
vetbrand
brazil
solut
total
blood
bal
fluid
collect
case
anim
perfus
ml
pb
remov
blood
content
tissu
lung
collect
process
describ
anim
surviv
monitor
daili
day
postbleomycin
case
death
experi
repeat
achiev
minim
number
anim
per
group
case
mice
treat
daili
mgkg
intraperiton
ip
peptid
acamvseflkqawfieneeqeyvqtvk
obtain
tocri
huissen
netherland
start
immedi
first
dose
bleomycin
bleopep
n
anoth
group
bleomycintr
mice
receiv
dose
rout
peptid
day
day
postbleomycin
bleopep
n
control
mice
treat
daili
ip
treat
salin
instead
bleomycin
case
anim
sacrif
day
lung
histolog
immunohistochemistri
western
blot
analys
wild
type
null
lung
excis
fix
paraformaldehyd
sodium
phosphat
buffer
ph
h
fragment
wash
dehydr
ethanol
clarifi
xylen
embed
sigma
usa
histolog
section
cut
leica
leica
gr
mount
slide
stain
masson
trichrom
quantif
leukocyt
number
tissu
sampl
perform
pointcount
techniqu
highpow
object
measur
area
analysi
softwar
axiovis
zeiss
gr
data
report
analyz
least
distinct
histolog
section
per
mous
total
lung
hydroxyprolin
content
determin
use
wellaccept
assay
briefli
sampl
lung
homogen
ad
ml
n
hydrochlor
acid
h
sampl
digest
lung
citrateacet
buffer
citric
acid
sodium
acet
sodium
hydroxid
glacial
acet
acid
ph
chloraminet
solut
mg
chloraminet
ml
npropanol
ml
distil
water
ml
citrateacet
buffer
ad
result
sampl
incub
room
temperatur
min
addit
ehrlich
solut
aldrich
milwauke
wi
ml
npropanol
ml
perchlor
acid
incub
sampl
min
sampl
read
nm
spectrophotomet
beckman
fullerton
ca
hydroxyprolin
concentr
calcul
standard
curv
hydroxyprolin
aliquot
blood
obtain
abdomin
arteri
dilut
turk
solut
crystal
violet
acet
acid
cell
quantif
semiexcis
trachea
plastic
cannula
insert
airspac
wash
ml
sodium
chlorid
contain
mm
edta
ml
syring
oper
repeat
twice
bal
centrifug
g
min
cellfre
supernat
frozen
subsequ
cytokin
analysi
cell
pellet
resuspend
aliquot
dilut
turk
solut
crystal
violet
acet
acid
cell
quantif
case
total
differenti
count
obtain
neubauer
chamber
use
object
light
microscop
axioskop
ii
mot
plu
zeiss
gr
bal
cell
distinguish
polymorphonuclear
pmn
mononuclear
phagocyt
cell
monocytemacrophag
mpc
lymphocyt
ly
wherea
blood
cell
divid
pmn
peripher
blood
monocyt
pbmc
ly
aliquot
blood
bal
fluid
centrifug
g
min
respect
concentr
tumor
necrosi
factor
tnf
transform
grow
factor
tgf
interferon
ifn
measur
use
specif
enzymelink
immunosorb
assay
kit
purchas
r
system
abingdon
uk
protein
express
tissu
cell
determin
immunohistochemistri
report
briefli
wild
type
lung
sampl
fix
paraformaldehyd
sodium
phosphat
buffer
h
ph
embed
lr
gold
resin
london
resin
uk
histolog
section
thick
block
albumin
bovin
pb
pbsa
polyclon
rabbit
antibodi
zyme
laboratori
ad
pbsa
overnight
neg
control
reaction
histolog
section
wild
type
lung
incub
nonimmun
rabbit
serum
work
dilut
sigmaaldrich
instead
primari
antibodi
goat
antirabbit
igg
fc
fragmentspecif
antibodi
conjug
nm
colloid
gold
british
biocel
intern
ad
silver
enhanc
solut
british
biocel
intern
use
augment
gold
particl
stain
histolog
section
counterstain
haematoxylin
analysi
express
conduct
axioskop
ii
microscop
zeiss
germani
stain
area
analyz
densitometricali
softwar
zeiss
determin
valu
cell
gener
valu
vari
arbitrari
unit
spatial
tempor
activ
gene
promot
lung
monitor
histochem
xgal
stain
report
monitor
prussian
blue
precipit
marker
lacz
gene
activ
briefli
tissu
fix
paraformaldehyd
sodium
phosphat
buffer
ph
h
wash
rins
buffer
phosphat
buffer
ph
mm
magnesium
chlorid
triton
sampl
stain
overnight
mm
potassium
ferricyanid
mm
potassium
ferrocyanid
rins
buffer
contain
mgml
dimethylformamid
sampl
embed
lr
resin
subsequ
microscopi
analysi
neg
control
reaction
wild
type
lung
incub
xgal
stain
densitometr
analysi
xgal
stain
perform
densitometricali
softwar
zeiss
lung
leukocyt
epitheli
cell
valu
gener
vari
arbitrari
unit
lung
control
experiment
group
wild
type
mice
homogen
edta
free
proteas
inhibitor
roch
uk
protein
concentr
determin
bradford
assay
sigma
mix
laemmli
sampl
buffer
equal
protein
amount
electrophores
polyacrylamid
gel
run
buffer
tri
base
glycin
sd
distil
water
follow
transfer
protein
onto
hybondc
extra
nitrocellulos
membran
transfer
buffer
tri
base
glycin
methanol
distil
water
membran
block
nonfat
milk
solut
tb
contain
tween
immunoreact
assess
use
specif
antibodi
detect
cleav
kda
intact
protein
kda
invitrogen
usa
signal
amplifi
hrplink
antimous
secondari
antibodi
amersham
bioscienc
usa
visual
ecl
western
blot
detect
reagent
amersham
bioscienc
usa
case
data
report
mean
sem
five
mice
per
group
statist
differ
group
determin
anova
follow
signific
bonferroni
test
case
probabl
valu
taken
signific
surviv
rate
analyz
use
kaplanmei
cumul
plot
comparison
group
perform
use
logrank
test
began
studi
monitor
protein
express
wild
type
gene
promot
activ
null
mice
bronchiolar
epitheli
cell
circul
migrat
leukocyt
tabl
report
cumul
data
obtain
densitometr
analys
predict
immunohistochemistri
reveal
intracellular
local
associ
gold
particl
bronchiol
epitheli
cell
figur
mononuclear
phagocyt
cell
mpc
circul
polymorphonuclear
pmn
figur
cell
posit
basal
condit
tabl
day
postbleomycin
increment
express
observ
bronchiolar
epithelium
figur
pmn
mpc
wild
type
mice
figur
quantit
data
shown
tabl
cellular
respons
longer
evid
day
figur
tabl
immunogold
stain
could
detect
absenc
primari
antibodi
figur
confirm
specif
stain
lung
taken
sham
mice
day
basal
gene
promot
activ
could
detect
bronchiolar
epithelium
figur
pmn
mpc
figur
colorimetr
reaction
markedli
augment
day
figur
l
day
figur
postbleomycin
epithelium
mpc
result
strongli
posit
later
timepoint
tabl
report
data
quantit
fashion
control
data
perform
xgal
stain
protocol
lung
taken
wild
type
mice
yield
color
figur
earli
respons
bleomycininduc
fibrosi
character
dramat
increas
inflammatori
cell
recruit
preced
fibrot
tissu
format
bleomycin
administr
induc
mark
leukocyt
influx
wild
type
mice
influx
blood
cell
found
untreat
mice
figur
quantit
analysi
sever
histolog
lung
section
null
wild
type
mice
reveal
rapid
intens
leukocyt
migrat
peribronchi
perivascular
area
also
interstiti
space
occur
day
postbleomycin
figur
day
mice
defici
display
higher
degre
pmn
peripher
blood
monocyt
pbmc
adhes
lung
microvessel
figur
analysi
sever
tissu
paramet
complement
quantif
blood
bal
total
leukocyt
number
wild
type
mice
bleomycin
administr
caus
mark
leukocytosi
day
high
number
circul
pmn
pbmn
lymphocyt
ly
calcul
addit
file
figur
profil
circul
leukocyt
subset
mildli
affect
absenc
reduct
ly
day
well
less
pronounc
increas
pmn
could
measur
day
addit
file
figur
parallel
analys
rapid
cell
influx
bloodborn
leukocyt
bal
fluid
detect
mark
chang
wild
type
null
mice
especi
pmn
day
day
pbmc
day
ly
day
addit
file
figur
assess
extent
pulmonari
fibrosi
genotyp
use
masson
trichrom
stain
administr
salin
either
wild
type
null
lead
abnorm
deposit
collagen
around
bronchiol
vessel
alveoli
figur
contrast
day
postbleomycin
wild
type
mice
show
signific
increas
connect
tissu
figur
sign
sever
fibrosi
evid
day
greater
destruct
alveolar
architectur
pronounc
perivascular
peribronchi
site
figur
chang
also
evid
null
mice
day
postbleomycin
figur
result
obtain
histopatholog
method
confirm
measur
hydroxyprolin
content
lung
tissu
sampl
quantifi
extent
collagen
deposit
wild
type
null
bleomycintr
mice
significantli
higher
fibrosi
score
salinetr
correspond
mice
addit
file
figur
moreov
statist
signific
differ
day
day
wild
type
null
bleomycintr
mice
indic
induct
higher
degre
pulmonari
fibrosi
latter
genotyp
addit
file
figur
observ
surpris
observ
proport
null
mice
succumb
timecours
experi
progress
incid
lethal
day
day
bleomycintr
mice
die
figur
lethal
observ
wild
type
anim
day
accept
key
cytokin
fibrot
process
lung
initi
bleomycin
thu
analyz
cytokin
level
possibl
caus
behind
increas
sign
fibrosi
collagen
accumul
detect
null
mice
figur
show
mark
timedepend
increas
circul
upon
bleomycin
treatment
wherea
chang
modest
fold
untreat
mice
day
valu
furthermor
higher
serum
level
measur
day
null
mice
similar
chang
seen
bal
fluid
sampl
discret
alter
valu
sampl
taken
null
mice
figur
exampl
bal
higher
day
bal
increas
day
mildli
affect
absenc
endogen
final
test
whether
treatment
wild
type
mice
mimet
would
affect
dramat
chang
provok
bleomycin
lung
two
protocol
use
administr
peptid
histolog
analys
show
peptid
treatment
reduc
extracellular
deposit
collagen
compar
mice
treat
bleomycin
alon
figur
group
mice
treat
peptid
daili
day
clear
reduct
connect
tissu
deposit
around
bronchiolar
epithelium
observ
similar
morpholog
structur
sham
group
figur
similar
protect
lung
afford
peptid
administ
day
postbleomycin
determin
quantif
lung
hydroxyprolin
content
figur
control
group
treat
daili
peptid
ip
given
salin
show
signific
morpholog
chang
lung
tissu
data
shown
treatment
mice
peptid
led
increas
express
endogen
protein
lung
figur
compar
bleomycin
treatment
alon
figur
chang
provok
peptid
occur
alveolar
macrophag
epitheli
cell
express
higher
sham
group
salin
treat
figur
respect
western
blot
analys
confirm
histolog
result
show
augment
lung
protein
extract
prepar
mice
treat
peptid
day
day
period
compar
bleomycintr
control
mice
figur
tabl
report
quantit
data
associ
analys
singl
cell
level
pulmonari
fibrosi
complex
etiolog
involv
interact
among
multipl
cell
type
intric
cytokinechemokin
network
howev
precis
role
one
cytokin
vivo
hard
identifi
view
pleiotrop
biolog
activ
studi
use
anim
model
afford
welldefin
mean
address
problem
sinc
provid
opportun
target
put
mediat
use
immunolog
genet
approach
line
human
fibrosi
mechan
underli
bleomycininduc
lung
fibrosi
fulli
understood
although
sever
studi
identifi
express
specif
cytokin
mediat
potenti
function
role
process
propos
investig
potenti
modul
effector
endogen
antiinflamm
could
provid
novel
clue
har
host
respons
lung
fibrosi
novel
approach
exploit
function
homeostat
tissu
protect
mediat
would
possibl
success
blockad
action
proinflammatori
mediat
sinc
anticytokin
therapi
produc
improv
lung
function
rather
seem
associ
harm
side
effect
studi
human
anim
demonstr
regul
one
endogen
effector
resolut
protein
develop
cystic
fibrosi
present
studi
intend
address
first
time
potenti
relev
experiment
fibrosi
use
recent
gener
null
mous
analysi
protein
express
bleomycininduc
fibrosi
indic
increas
express
bronchial
epitheli
cell
leukocyt
inflammatori
phase
day
follow
reduct
fibrot
phase
day
compar
sham
anim
event
agreement
chang
report
lung
tissu
leukocyt
experiment
set
model
tissu
fibrosi
could
monitor
gene
promot
activ
leukocyt
epitheli
cell
use
null
mous
coloni
lacz
gene
report
assay
insert
frame
day
postbleomycin
xgal
stain
detect
higher
gene
promot
activ
leukocyt
epitheli
cell
compar
day
lung
tissu
sampl
data
togeth
protein
express
indic
despit
lower
level
detect
cell
ampl
gene
promot
activ
wish
postul
reduct
protein
may
associ
posttranscript
mechan
could
perhap
lead
proteolysi
leakag
aberr
secret
cell
lack
signal
peptid
yet
releas
cell
eg
activ
pmn
see
ref
sever
noncanon
secretori
pathway
ascrib
possibl
cell
specif
fashion
includ
phosphoryl
proteolysi
granulemembran
fusion
microparticl
releas
futur
studi
attempt
establish
prefer
mode
secret
activ
lung
cell
though
exclud
altern
mechan
might
oper
diseas
cell
day
could
also
measur
higher
degre
fibrosi
collagen
deposit
null
anim
detect
morpholog
hydroxyprolin
measur
therefor
downregul
might
import
determin
lung
fibrosi
develop
suggest
manipul
local
pulmonari
concentr
perhap
adenovir
deliveri
rout
success
appli
lung
patholog
might
repres
novel
way
afford
lung
tissu
protect
implic
mani
aspect
cell
physiolog
includ
regul
cell
growth
differenti
signal
transduct
arachidon
acid
releas
well
intracellular
vesicl
traffick
moreov
promot
cell
apoptosi
possibl
relev
phagocytosi
apoptot
cell
subsequ
tissu
clearanc
also
ascrib
homeostat
mediat
croxtal
et
al
show
lung
fibroblast
cell
line
deriv
null
mous
refractori
growth
inhibit
dexamethason
indic
intracellular
though
exclud
also
extracellular
role
function
neg
regul
cell
growth
patholog
implic
directli
indirectli
tumor
cell
growth
previou
result
also
show
abnorm
growth
format
null
mice
skull
probabl
caus
increas
extracellular
matrix
delay
bone
miner
thu
would
postul
absenc
may
lead
higher
cell
prolifer
increas
extracellular
matrix
product
fibrosi
format
studi
nusrat
lab
identifi
major
effector
tissu
protect
follow
epitheli
damag
effect
requir
extern
protein
experiment
condit
absenc
affect
sever
indic
respons
promot
bleomycin
character
earli
inflammatori
phase
follow
fibrot
process
combin
effect
absenc
bleomycininduc
fibrosi
exceed
sum
effect
factor
alon
sever
histolog
chang
visibl
higher
degre
activ
circul
leukocyt
remark
leukocyt
infiltr
alveolar
space
lung
parenchyma
cellular
event
led
least
contribut
sever
inflammatori
respons
ii
greater
destruct
alveolar
architectur
pronounc
perivascular
peribronchi
area
effect
line
previou
data
differ
experiment
model
inflamm
includ
acut
periton
lipopolysaccharideinduc
system
inflamm
absenc
conduc
increas
leukocyt
infiltr
lead
sever
inflammatori
reaction
sever
studi
associ
inflammatori
cell
recruit
lung
damag
fibrosi
format
prompt
us
propos
alter
earli
protect
role
inflammatori
phase
could
lead
downstream
higher
degre
fibrosi
far
two
feasibl
mechan
explain
impact
model
direct
alter
phenotyp
lung
cell
potenti
necessarili
relat
ii
aggress
inflammatori
reaction
analysi
cytokin
content
favor
function
associ
two
readout
fact
tightli
coupl
earli
inflammatori
respons
higher
cytokin
express
measur
sinc
instrument
inflammatori
process
andor
fibrosi
wild
type
mice
level
cytokin
chang
blood
bal
fluid
sampl
larg
respons
fibroblast
activationdifferenti
well
collagen
overexpress
furthermor
lower
degre
parenchym
inflamm
observ
defici
mice
subject
bleomycininduc
lung
fibrosi
model
sampl
could
determin
correl
increas
level
upregul
hardi
collabor
show
condit
overexpress
epitheli
cell
endotheli
cell
macrophag
induc
fibrosi
express
even
absenc
inflamm
plausibl
complex
posit
loop
might
activ
local
sinc
induct
macrophag
occur
twostag
process
requir
global
absenc
result
dysregul
pulmonari
level
evid
day
yet
present
also
day
postbleomycin
associ
express
total
unexpect
previous
report
model
system
endotoxemia
induc
lp
studi
better
address
molecular
event
behind
regul
cytokin
product
lung
cell
final
test
potenti
pharmacolog
benefit
treatment
mice
peptid
peptid
mimic
pharmacolog
action
given
daili
day
day
peptid
reduc
remark
featur
anim
respons
bleomycin
fibrosi
quantifi
histolog
determin
lung
hydroxyprolin
content
interest
observ
stem
experi
posit
effect
treatment
mice
peptid
tissu
level
indic
posit
loop
might
exist
antiinflamm
wherebi
activ
receptor
activ
achiev
pharmacophor
peptid
would
augment
synthesi
epitheli
cell
leukocyt
subset
tabl
model
congruent
recent
studi
mous
coliti
reveal
abil
treatment
peptid
increas
tissu
mrna
receptor
held
true
epitheli
cell
treat
therefor
differ
studi
come
togeth
indic
exist
posit
loop
extend
set
would
indic
possibl
autoreact
endogen
antiinflamm
resolut
least
respect
pathway
summari
strike
phenotyp
describ
indic
endogen
exogen
affect
select
aspect
process
fibrosi
develop
lung
featur
may
warrant
investig
biolog
experiment
patholog
set
annexin
bal
bronchoalveolar
lavag
bleo
bleomycin
ecm
extracellular
matrix
ly
lymphocyt
mpc
mononuclear
phagocyt
cell
pbmc
peripher
blood
monocyt
pb
phosphatebuff
salin
pmn
polymorphonuclear
transform
growth
tumor
necrosi
author
declar
compet
interest
asd
particip
design
studi
carri
experi
particip
sequenc
align
draft
manuscript
alf
carri
experi
cmagn
carri
histopatholog
analysi
rjf
provid
de
transgen
mice
help
discuss
manuscript
mp
conceiv
studi
particip
design
coordin
help
draft
manuscript
smo
particip
design
studi
particip
sequenc
align
draft
manuscript
author
read
approv
final
manuscript
